Similar articles for PMID: 36854512

Year	Number of Results
2007	1
2008	1
2009	1
2010	4
2011	5
2012	3
2013	8
2014	9
2015	10
2016	13
2017	9
2018	7
2019	11
2020	15
2021	10
2022	12
2023	2
2024	0

1

Lung Cancer - Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators.

Check JH, Poretta T, Check D, Srivastava M. Check JH, et al. Anticancer Res. 2023 Mar;43(3):951-965. doi: 10.21873/anticanres.16240. Anticancer Res. 2023. PMID: 36854512 Review.

2

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.

Rossing HH, Grauslund M, Urbanska EM, Melchior LC, Rask CK, Costa JC, Skov BG, Sørensen JB, Santoni-Rugiu E. Rossing HH, et al. BMC Res Notes. 2013 Nov 26;6:489. doi: 10.1186/1756-0500-6-489. BMC Res Notes. 2013. PMID: 24279718 Free PMC article.

3

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.

Dudnik E, Moskovitz M, Rottenberg Y, Lobachov A, Mandelboim R, Shochat T, Urban D, Wollner M, Nechushtan H, Rotem O, Zer A, Daher S, Bar J; Israel Lung Cancer Group. Dudnik E, et al. Oncoimmunology. 2021 Jan 28;10(1):1865653. doi: 10.1080/2162402X.2020.1865653. Oncoimmunology. 2021. PMID: 33552685 Free PMC article.

4

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.

Jin R, Liu C, Zheng S, Wang X, Feng X, Li H, Sun N, He J. Jin R, et al. Cancer Biol Med. 2020 Aug 15;17(3):768-781. doi: 10.20892/j.issn.2095-3941.2020.0121. Cancer Biol Med. 2020. PMID: 32944405 Free PMC article.

5

MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.

Reis H, Metzenmacher M, Goetz M, Savvidou N, Darwiche K, Aigner C, Herold T, Eberhardt WE, Skiba C, Hense J, Virchow I, Westerwick D, Bogner S, Ting S, Kasper S, Stuschke M, Nensa F, Herrmann K, Hager T, Schmid KW, Schuler M, Wiesweg M. Reis H, et al. Clin Lung Cancer. 2018 Jul;19(4):e441-e463. doi: 10.1016/j.cllc.2018.03.010. Epub 2018 Mar 17. Clin Lung Cancer. 2018. PMID: 29631966

6

Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype.

Pandey RK, Shukla S, Husain N, Islam MH, Hadi R, Kant Tripathi S, Singhal A. Pandey RK, et al. Asian Pac J Cancer Prev. 2022 Jan 1;23(1):131-142. doi: 10.31557/APJCP.2022.23.1.131. Asian Pac J Cancer Prev. 2022. PMID: 35092381 Free PMC article.

7

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.

Rybarczyk-Kasiuchnicz A, Ramlau R, Stencel K. Rybarczyk-Kasiuchnicz A, et al. Int J Mol Sci. 2021 Jan 8;22(2):593. doi: 10.3390/ijms22020593. Int J Mol Sci. 2021. PMID: 33435596 Free PMC article. Review.

8

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.

Shea M, Costa DB, Rangachari D. Shea M, et al. Ther Adv Respir Dis. 2016 Apr;10(2):113-29. doi: 10.1177/1753465815617871. Epub 2015 Nov 30. Ther Adv Respir Dis. 2016. PMID: 26620497 Free PMC article. Review.

9

Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.

Xue Y, Gao S, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X, Wu R. Xue Y, et al. Expert Opin Drug Deliv. 2021 Feb;18(2):187-203. doi: 10.1080/17425247.2021.1825376. Epub 2020 Oct 5. Expert Opin Drug Deliv. 2021. PMID: 32954856 Review.

10

Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein.

Check JH, Dix E, Sansoucie L. Check JH, et al. Med Hypotheses. 2009 Jan;72(1):87-90. doi: 10.1016/j.mehy.2008.05.042. Epub 2008 Oct 7. Med Hypotheses. 2009. PMID: 18842348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year